Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Investigation on the Genomic Characterization of Uterine Sarcoma for rAd-p53 Combined with Chemotherapy Treatment.

Human gene therapy - 1 Aug 2020

Xia Yu, Wang Lei, Ma Xiaolin, Li Xiuqin

Abstract excerpt

The aim is to investigate the genomic characterization of uterine sarcoma for rAd-p53 (Gendicine®) combined with chemotherapy treatment. We recently published an article on 12 cases of uterine sarcomas, which were treated with rAd-p53 combined with chemotherapy. We found that rAd-p53 combined with chemotherapy is effective for various uterine sarcomas. Pretreatment pathological specimens of four uterine sarcoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoviridae
Share to Antineoplastic Agents
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Therapy

Share to High-Throughput Nucleotide Sequencing

Share to Sarcoma

Share to Tumor Suppressor Protein p53

Share to Uterine Neoplasms

Source

Identifiers

PMID: 32013587
DOI: 10.1089/hum.2019.305

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Investigation on the Genomic Characterization of Uterine Sarcoma for rAd-p53 Combined with Chemotherapy Treatment.PMID 32013587Read ↗

Advances in sarcoma gene mutations and therapeutic targets.Semantic proximity Read ↗

Molecular diversity in uterine carcinosarcoma: Beyond TP53.Semantic proximity Read ↗

Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma.Semantic proximity Read ↗

The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study.Semantic proximity Read ↗

Genomic Database Analysis of Uterine Leiomyosarcoma Mutational ProfileSemantic proximity Read ↗

The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical Implications.Semantic proximity Read ↗

Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.Semantic proximity Read ↗

Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcomaSemantic proximity Read ↗

Integrated Molecular Characterization of Uterine Carcinosarcoma.Semantic proximity Read ↗

Retrospective Analysis of BRCA -Altered Uterine Sarcoma Treated With Poly(ADP-ribose) Polymerase InhibitorsSemantic proximity Read ↗

Real‐World Data of Comprehensive Cancer Genomic Profiling Tests Performed in the Routine Clinical Setting in SarcomaSemantic proximity Read ↗

Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal SarcomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.